Market Factors At Play
Disposable medical device sensors are cost-effective and efficient devices that are generally used to detect and diagnose diseases in patients. These tools are used for patient monitoring by measuring basic vital signs such as heart rate, respiration rate, level of blood oxygenation, pulse rate, and temperature. In addition, disposable medical sensor devices play a crucial role in detecting the disease that causes microbes such as viruses, bacteria, and fungi.
The most important growth drivers for the disposable medical sensors market are an increase in the geriatric population coupled with the prevalence of rising diseases related to cardiovascular, and kidney disorders. In addition, increasing demand for convenient and cost-effective disposable medical devices has seen a surge in demand.
The market for disposable medical sensors is expected to be powered by technological advancements such as the cancer monitoring system, Micro-Electro-Mechanical Systems (MEMS) sensor technology, and fiber optic technology. Furthermore, government efforts to support R&D to launch innovative products are further expected to positively impact the growth of the market.
Region Specific Insights
The North America region dominates the global disposable medical sensors market owing to the involvement of a large number of industry players, and strengthened healthcare services along with growing local demand for disposable medical sensors. Furthermore, technological developments in sensor technology for medical devices have driven market growth in the region.
The Asia Pacific region is expected to see a high growth in the coming years owing to the innovative applications of medical sensors and increased awareness about therapeutic applications of disposable medical sensors in the region. It is expected that the growing economies such as India and China will lead to growth in the region's demand for disposable medical device sensors.
Recent Significant Developments
In March 2019, Sensirion launched a sensor-connector-cable solution that provides accurate, patient-side measurement while delivering a reliable flow signal to the ventilator. The solution includes different options of cables and connectors in order to reliably transport calibrated and temperature-compensated output signals of the sensor back to the ventilator.
In April 2020, The University Medical Center Utrecht (UMCU) in the Netherlands along with Philip's smart patient monitoring technology, said that it is remotely monitoring COVID-19 patients in isolation rooms using a biosensor. Together with Philips, UMCU has developed a solution to monitor these patients continuously yet remotely, reducing the number of times the nursing staff needs to enter the patient’s room.
In May 2019, Royal Philips announced a collaboration with Medtronic to further advance the treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder. Through the partnership, Medtronic will facilitate sales of products on behalf of Philips to provide an innovative, image guidance solution for cryoablation procedures. Philips will launch the novel KODEX-EPD cardiac imaging and navigation system with cryoablation specific features to enable electrophysiologists to perform cryoablation procedures with reduced need for X-ray imaging.
No comments:
Post a Comment